Literature DB >> 2045826

Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions.

M A Moskowitz1, M G Buzzi.   

Abstract

The results of recent investigations designed to elucidate the neuroeffector functions of sensory fibres, the cause of migraine headache and the mechanism of action of antimigraine drugs are reviewed and discussed. Neurogenic inflammation (vasodilatation and neurogenic plasma extravasation) is one explanation for the development of headaches and the blood flow changes which occur during migraine headache. Numerous studies have recently been carried out on rats and guinea-pigs into the effects of antimigraine agents, including ergot alkaloids, sumatriptan and non-steroidal anti-inflammatory drugs (NSAIDs), on neurogenic plasma protein extravasation in the dura mater induced by electrical stimulation of trigeminal ganglia or systemic administration of capsaicin. It is known that the dura mater is able to produce headaches in man. Ergot alkaloids have been shown to block neurogenic inflammation via a C-fibre dependent neuronal mechanism. Sumatriptan appears to act fairly similarly although, whereas the ergot alkaloids are non-selective for either 5-hydroxytryptamine (5-HT; serotonin) receptors or 5-HT1, sumatriptan is selective for 5-HT1 receptors. The antimigraine action of NSAIDs may be via either an effect on blood vessels or an effect on the nerve fibre. The antimigraine effects of ergot alkaloids, sumatriptan and NSAIDs are discussed in the light of the common vasoconstrictor actions of these agents and knowledge that vasodilatation is apparently not responsible for migraine headache pain in most cases.

Entities:  

Mesh:

Year:  1991        PMID: 2045826     DOI: 10.1007/bf01642901

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  22 in total

1.  Preproenkephalin upregulation in nucleus caudalis: high and low intensity afferent stimulation differentially modulate early and late responses.

Authors:  T Nishimori; M G Buzzi; E H Chudler; C E Poletti; M A Moskowitz; G R Uhl
Journal:  J Comp Neurol       Date:  1990-12-22       Impact factor: 3.215

2.  Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin.

Authors:  N Jancsó; A Jancsó-Gábor; J Szolcsányi
Journal:  Br J Pharmacol Chemother       Date:  1967-09

3.  The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater.

Authors:  M G Buzzi; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

4.  Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites.

Authors:  S J Peroutka; B G McCarthy
Journal:  Eur J Pharmacol       Date:  1989-04-12       Impact factor: 4.432

5.  Facial flushing after thermocoagulation of the Gasserian ganglion.

Authors:  P D Drummond; A Gonski; J W Lance
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-07       Impact factor: 10.154

6.  Vascular protein linkage in various tissue induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge.

Authors:  A Saria; J M Lundberg; G Skofitsch; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

7.  Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system.

Authors:  P J Goadsby; L Edvinsson; R Ekman
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

8.  Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine.

Authors:  A Doenicke; J Brand; V L Perrin
Journal:  Lancet       Date:  1988-06-11       Impact factor: 79.321

9.  Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain.

Authors:  S Markowitz; K Saito; M A Moskowitz
Journal:  J Neurosci       Date:  1987-12       Impact factor: 6.167

10.  Vascular permeability changes and smooth muscle contraction in relation to capsaicin-sensitive substance P afferents in the guinea-pig.

Authors:  J M Lundberg; E Brodin; X Hua; A Saria
Journal:  Acta Physiol Scand       Date:  1984-02
View more
  12 in total

Review 1.  5-HT3 receptor antagonists and migraine therapy.

Authors:  M D Ferrari
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

Review 2.  Rationale for the use of 5-HT1-like agonists in the treatment of migraine.

Authors:  W Feniuk; P P Humphrey; M J Perren; H E Connor; E T Whalley
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

3.  Innervation of the dura mater encephali of cat and rat: ultrastructure and calcitonin gene-related peptide-like and substance P-like immunoreactivity.

Authors:  K Messlinger; U Hanesch; M Baumgärtel; B Trost; R F Schmidt
Journal:  Anat Embryol (Berl)       Date:  1993-09

4.  CSD-Induced Arterial Dilatation and Plasma Protein Extravasation Are Unaffected by Fremanezumab: Implications for CGRP's Role in Migraine with Aura.

Authors:  Aaron J Schain; Agustin Melo-Carrillo; Jennifer Stratton; Andrew M Strassman; Rami Burstein
Journal:  J Neurosci       Date:  2019-05-24       Impact factor: 6.167

5.  Anti-hyperalgesic effects of anti-serotonergic compounds on serotonin- and capsaicin-evoked thermal hyperalgesia in the rat.

Authors:  D R Loyd; P B Chen; K M Hargreaves
Journal:  Neuroscience       Date:  2011-12-20       Impact factor: 3.590

6.  Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption.

Authors:  H Kaube; K L Hoskin; P J Goadsby
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

Review 7.  Serotonergic neuromodulation of peripheral nociceptors.

Authors:  Dayna R Loyd; Michael A Henry; Kenneth M Hargreaves
Journal:  Semin Cell Dev Biol       Date:  2012-09-19       Impact factor: 7.727

Review 8.  Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache.

Authors:  K L Dechant; S P Clissold
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

9.  Interleukin-1 beta enhances capsaicin-induced neurogenic vasodilatation in the rat skin.

Authors:  M K Herbert; P Holzer
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

10.  Causes and mechanisms of primary headaches: toward a bio-behavioral model.

Authors:  M G Buzzi; M G Pellegrino; P Bellantonio
Journal:  Ital J Neurol Sci       Date:  1995-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.